Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q4 FY2026 Earnings Presentation
45 slides from Balaji Amines's earnings presentation, May 15, 2026
Slide 1: Exchange cover letter: Investor Presentation on Q4FY26 Results
15th May, 2026 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (
Slide 2: Investor Presentation – March 2026
Investor Presentation – March 2026
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 3
Slide 5: Q4FY26: Financial Highlights
Q4FY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin EBITD A PA T Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26 Q4FY26 Consolidated Revenue EBITDA PAT EBITDA & PAT Margin EBITD A PA T Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26 Q4FY26 Q4FY
Slide 6: Q4 FY26 - Consolidated Performance Highlights
Q4 FY26 - Consolidated Performance Highlights Revenue from Operations for Q4FY26 stood at ₹ 403 crore, as compared to ₹ 336 crore in Q3FY26, indicating a stable operational performance. Volumes were maintained at similar levels in comparison to Q4FY25, supported by stable commodity prices and consis
Slide 7: Q4 FY26 - Consolidated Performance Highlights
| Q4 FY26 - Consolidated Performance Highlights tet ese Revenue from Operations for Q4FY26 stood at = 403 crore, as compared to % 336 crore in Q3FY26, indicating a stable operational performance. Volumes were maintained at similar levels in comparison to Q4FY25, supported by stable commodity prices
Slide 8: New Project Highlights (1/2)
New Project Highlights (1/2) Update on New Proposed Products/Projects: • Dimethyl Ether (DME) Plant is expected to be commissioned during First Quarter of FY 2026-27. This has an application in the Aerosol industry apart from being using it as a replacement to LPG for Industrial and Commercial usage
Slide 9: New Project Highlights (2/2)
New Project Highlights (2/2) New expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited • Investment is being made for wide range of products, including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) 30%(Solution), Sodium Cyanide (NaCN) 100%(Pellets), Ethylene Diamine Tetra Acetic
Slide 10: Expansion Plans
Expansion Plans EXECUTED ON SCHEDULE (Methylamines) IN PROGRESS (Dimethyl Ether) • Market Leader in Methylamines production in India with installed capacity • Dimethyl Ether (DME) with a Capacity of 1,00,000 tons per annum under of 48,000 TPA being increased to 88,000 TPA Phase-3 expansion a new age
Slide 11: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q4FY26 Q4FY25 Y-o-Y Q3FY26 Q-o-Q FY26 FY25 Y-o-Y Total Revenue 370 327 13.20% 307 20.58% 1320 1296 1.82% Raw Material 190 179 168 710 706 Employee expense 24 21 16 77 73 Other expenses 61 64 62 257 268 EBITDA 94 64 47.63%
Slide 12: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q4FY26 Q4FY25 Y-o-Y Q3FY26 Q-o-Q FY26 FY25 Y-o-Y Total Revenue 403 361 11.71% 336 19.94% 1,454 1,430 1.64% Raw Material 221 198 184 796 781 Employee expense 26 23 18 84 80 Other expenses 53 72 74 279 304 EBITDA 102 68 5
Slide 13: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement ASSETS (Rs. Crs.) Mar-26 Mar-25 EQUITY AND LIABILITIES (Rs. Crs.) Mar-26 Mar-25 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 1,035 998 (a) Equity Share capital 6 6 (b) Capital work-in-progress 512 234 (b) Other equity 1970 1,839 Attributable to o
Slide 14: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Mar-26 Mar-25 Profit before Tax 232 213 Adjustment for Non-Operating Items 45 31 Operating Profit before Working Capital Changes 277 244 Changes in Working Capital -59 53 Cash Generated from Operations 218 29
Slide 15: About Us
Results Highlights About Us Historical Financial Performance Annexures 14
Slide 16: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential Globally, ~61% of aliphatic amines and Top six companies control around 50% In terms of the usage, Aliphatic Amines The Amines Market is projected to grow amine-based chemicals get consumed of the global capacities. China is the an
Slide 17: Balaji Amines – Pioneers in Amines & Specialty Chemicals
Balaji Amines – Pioneers in Amines & Specialty Chemicals State-of-the-art manufacturing Forward integrated suite of 50+ 40+ facilities fully equipped with products latest DCS Downstream products added based on strength of amine manufacturing which have value technology Countries Product basket addit
Slide 18: Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals
Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals Particulars Amines Amine Derivatives Specialty & Other Chemicals o Aliphatic Amines find increasing consumption o Amine Derivatives are used to make further and applications in a Chemically mature salts and other complex chemical I
Slide 19: Robust Manufacturing Backbone with Scalable Capacities
Robust Manufacturing Backbone with Scalable Capacities Existing Installed Proposed Capacity Total Capacity after Product Capacity Application Areas (TPA) Expansions (TPA) (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMA
Slide 20: Robust Manufacturing Backbone with Scalable Capacities of BSCL
Robust Manufacturing Backbone with Scalable Capacities of BSCL Existing Installed Proposed Capacity Total Capacity after Product Capacity Application Areas (TPA) Expansions (TPA) (TPA) Pharma, Fungicides, Pesticides, Polymers and Ethylenediamine 37,350 - 37,350 Coatings Balaji Speciality Chemicals P
Slide 21: Well-Positioned Across Essential and Evolving Industries
Well-Positioned Across Essential and Evolving Industries Investor Presentation 20
Slide 22: Expanding Global Footprint Across Key Export Markets
Expanding Global Footprint Across Key Export Markets • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatemala • South Africa
Slide 23: Trusted by Industry Leaders Across the Globe
Trusted by Industry Leaders Across the Globe Amines Amine Derivatives Specialty & Other Chemicals Investor Presentation 22
Slide 24: Integrated Value Chain Enhancing Operational Resilience
Integrated Value Chain Enhancing Operational Resilience Value-Added Products Robust Logistics Capabilities Preference for Local Sourcing Exposure to pharma sector Capex towards high-value Efficient logistics ensures safe Safety is a critical factor and Extensive usage in solvents led to derivatives
Slide 25: Distinctive Strengths Powering Our Competitive Edge
Distinctive Strengths Powering Our Competitive Edge Extensive Geographical Presence Market Leadership and Unique Positioning Strategic manufacturing footprint and global supply chain ensure Largest manufacturer of Aliphatic unmatched market responsiveness, cost-efficient logistics, and risk Amines i
Slide 26: Focused Strategy to Enhance Value Across the Value Chain
Focused Strategy to Enhance Value Across the Value Chain Value Added Products Target fast growing industries Focus towards high-value derivatives and Cater to fast growing industries, namely, specialty chemicals with an aim to move pharmaceuticals, agro-chemicals, refineries, up the value-chain with
Slide 27: Poised for the Next Phase of Scalable, Profitable Growth (1/2)
Poised for the Next Phase of Scalable, Profitable Growth (1/2) Strategically Located Remaining plants under Balaji Specialty Product Profile Plant Mega Project plan Chemicals All the plants of Balaji Amines Dimethyl Ether (DME) plant is Electronic Grade DMC Existing are located in and around ready t
Slide 28: Poised for the Next Phase of Scalable, Profitable Growth (2/2)
Poised for the Next Phase of Scalable, Profitable Growth (2/2) New Products = First High Demand for Solar Power Plant Mover advantage Products Significant opportunity exists to The demand of Methylamines has Out of the planned 20 MW introduce new products & gain increased in India. High demand Green
Slide 29: About Balaji Speciality Chemicals
About Balaji Speciality Chemicals 01 02 03 Balaji Speciality Chemicals Limited (BSCL) is Commenced its commercial operations in June 2019 Manufacturing products such as Ethylene Diamine BAL owns 55% in subsidiary Balaji Speciality Chemicals Pvt. Ltd which is strategically located at from its state o
Slide 30: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel o Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur o Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity o Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 31: Balaji Sarovar Premiere – Q4FY26 Operating Matrix
Balaji Sarovar Premiere – Q4FY26 Operating Matrix Constitutes Rs 917.90 129 Rooms 2.75% of Lakhs Rs. 5,378 from Hotel ARR Total Revenue Division Business 76% Rs. 4,080 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ADR: Average Daily Rate RevPAR: Revenue per Available Room Inv
Slide 32: Historical Financial Performance
Results Highlights About Us Historical Financial Performance Annexures 31
Slide 33: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2022 2023 2024 2025 2026 2022 2023 2024 2025 2026 2022 2023 2024 2025 2026 EBITDA Margin (%) PAT Margin (%) RoE (%) 27.3% 26.3% 17.9% 17.1% 31.8% 21.0% 14.0% 26.1% 18.5% 11.1% 13.5% 8.6% 2022 2023 2024 2025 2026
Slide 34: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY26 FY25 During the year the following plants have been commissioned Consolidated Debt 133 11 1) Iso Propyl Amine 2) Standalone Solar Power Plants of 6 MW AC capacity under Open Access to set off our Consolidated Networth 2152 2018 power requirements
Slide 35: Consistent Dividend Payout
Consistent Dividend Payout 550% 550% 550% 500% 300% 200% FY21 FY22 FY23 FY24 FY25 FY26 Particulars (Rs. per share) FY21 FY22 FY23 FY24 FY25 FY26 Consolidated Book Value 281 406 524 584 623 664 Consolidated EPS 74 114 100 63 49 52 Dividend 4.00 6.00 10.00 11.00 11.00 11.00 Investor Presentation 34
Slide 36: Annexures
Results Highlights About Us Historical Financial Performance Annexures 35
Slide 37: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily Unit 4: Increased Unit 4 : Capex for Phase 2 & 3 of Greenfield Capex to be capacity utilization & 1 Capex Phase - 2 & 3 completed till FY 2027 2 capacity additions of Higher capacity utilization of new Ethylamines plant Phase - 1 capex Dimethyl Ether (DME) pl
Slide 38: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Prathap Reddy Mr. N. Rajeshwar Reddy Executive Chairman Whole Time Director • Civil Engineer by Education. Incorporated BAL in • Commerce Graduate having over 48 years of 1988 experience across industries • BAL's continuing success is a testimony to his • In
Slide 39: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Three Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP Certificate of Merit - ISO 9001 : 2015 Certificate First Award - CHEMEXCIL WHO GMP Certificate 02.05.2
Slide 40: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities Investor Presentation 39
Slide 41: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities Balaji Sarovar Premiere As “International Tourism & proudly upholds its legacy “Winner at the India Risk Hospitality Award for the Best with 1st place on Tripadvisor Niryat Shree Award by FIEO Reach Pre-Registration Mahatma Award Management Awa
Slide 42: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre
Slide 43: ESG & CSR Initiatives
ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay Gotewadi, University, Solapur dt. 10.12.2024 Penur,Mohol, Solapur dt 07.06.2024 Mohol, Solapur dt.09.10.2024 Constructed
Slide 44: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Bhimgal, Construction of Toilet Block at Indira Kale Prashala, Jalkotwadi, Distributed Sanitary Napkin Incinerator and Vending Machine at Nizamabad, dt. 04.01.2025 dt. 25.03.2025 Vishwabhushan Vidyalay, Solapur dt.30.09.2024
Slide 45: Thank You
Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 cs@balajiamines.com Email - cs@balajiamines.com www.balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Nikunj